Sabine D. Brookman-May (@brookmans76) 's Twitter Profile Photo

Excellent talks Sarah P. Psutka MD MS and Prof Param Mariappan 🇬🇧 🇲🇾 on disease management of LG IR #NMIBC Are #chemoablation, fulguration, #ActiveSurveillance proper options? A risk adapted approach based on rigorous diagnosis and #IBCG risk criteria might be most recommendable #AUA24 #BladderCancer

Excellent talks <a href="/spsutkaMD/">Sarah P. Psutka MD MS</a> and <a href="/ParamMariappan/">Prof Param Mariappan 🇬🇧 🇲🇾</a> on disease management of LG IR #NMIBC
Are #chemoablation, fulguration, #ActiveSurveillance proper options? A risk adapted approach based on rigorous diagnosis and #IBCG risk criteria might be most recommendable #AUA24 #BladderCancer
Urology Research and Practice (@turkjurol) 's Twitter Profile Photo

Role of Chemoablation Using UGN-101 in Upper Tract Urothelial Carcinoma: A Systematic Review and MetaAnalysis of Available Evidence Abdalla Deb et al. #urothelialcancer #chemoablation #mitomycin #metaanalysis Link : urologyresearchandpractice.org/en/role-of-che…

Role of Chemoablation Using UGN-101 in Upper Tract Urothelial Carcinoma: A Systematic Review and MetaAnalysis of Available Evidence

<a href="/AbdallaDeb/">Abdalla Deb</a> et al.

#urothelialcancer #chemoablation #mitomycin #metaanalysis

Link :

urologyresearchandpractice.org/en/role-of-che…
Sabine D. Brookman-May (@brookmans76) 's Twitter Profile Photo

Results from #ChemoAblation ENVISION study with UGN-102 in IR #NMIBC presented at #SUO23 79% complete response at 3 months is a promising outcome, but only clinically meaningful when stable over a longer time + at least as effective as #TURBT Curious to see longer term data soon

Results from #ChemoAblation ENVISION study with UGN-102 in IR #NMIBC presented at #SUO23 
79% complete response at 3 months is a promising outcome, but only clinically meaningful when stable over a longer time + at least as effective as #TURBT Curious to see longer term data soon
Mary Ann Liebert Inc (@liebertpub) 's Twitter Profile Photo

Check out the first episode of "Chemoablation in Urothelial Cancer", a new podcast series brought to you by Journal of Endourology Endourological Society UroGen Pharma! All About #Chemoablation: The Emerging Treatment for #UrothelialCancer -- Listen now: ow.ly/aVq650F4Q9h

Check out the first episode of "Chemoablation in Urothelial Cancer", a new podcast series brought to you by <a href="/JEndourology/">Journal of Endourology</a> <a href="/Endo_Society/">Endourological Society</a> <a href="/UroGenPharma/">UroGen Pharma</a>! 

All About #Chemoablation: The Emerging Treatment for #UrothelialCancer -- Listen now: ow.ly/aVq650F4Q9h
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

Also in the June issue: Primary #chemoablation of low-grade upper tract #urothelialcarcinoma using UGN-101, a mitomycin-containing reverse thermal gel—the phase 3 OLYMPUS trial #bladdercancer thelancet.com/journals/lanon…

The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

Online first: Primary #chemoablation of low-grade upper tract #urothelialcarcinoma using UGN-101, a mitomycin-containing reverse thermal gel—the phase 3 OLYMPUS trial thelancet.com/journals/lanon…

Online first: Primary #chemoablation of low-grade upper tract #urothelialcarcinoma using UGN-101, a mitomycin-containing reverse thermal gel—the phase 3 OLYMPUS trial  
thelancet.com/journals/lanon…
Grand Rounds Urology (@grurology) 's Twitter Profile Photo

There is an unmet need for an effective #KidneySparing therapy for low-risk #UTUC patients. David S. Morris, MD, FACS, describes the OLYMPUS trial and the potential for #chemoablation with UGN-101 to address this need here: hubs.ly/H0m2Dls0 #UroSoMe